Activated Partial Thromboplastin Time measurement
|
phenotype |
|
Laboratory Procedure
|
17
|
44
|
0.100 |
None |
1.000 |
2 |
3
|
2013 |
2018 |
Alzheimer's Disease
|
disease |
Nervous System Diseases; Mental Disorders
|
Disease or Syndrome
|
3397
|
1843
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Amino acids measurement
|
group |
|
Laboratory Procedure
|
53
|
92
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Angioedemas, Hereditary
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases; Immune System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
54
|
7
|
0.100 |
None |
1.000 |
18 |
|
1985 |
2019 |
Arthritis
|
disease |
Musculoskeletal Diseases
|
Disease or Syndrome
|
1072
|
69
|
0.030 |
None |
1.000 |
3 |
|
2017 |
2018 |
arthritis symptoms
|
disease |
|
Disease or Syndrome
|
9
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Asthma
|
disease |
Respiratory Tract Diseases; Immune System Diseases
|
Disease or Syndrome
|
2096
|
1536
|
0.010 |
None |
1.000 |
1 |
1
|
2014 |
2014 |
BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases
|
Disease or Syndrome
|
12
|
36
|
0.100 |
None |
|
0 |
6
|
|
|
Blood Coagulation Disorders
|
group |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
267
|
31
|
0.320 |
strong |
1.000 |
3 |
|
1974 |
2017 |
Blood Protein Measurement
|
phenotype |
|
Laboratory Procedure
|
1156
|
2575
|
0.100 |
None |
1.000 |
2 |
16
|
2018 |
2018 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6776
|
2793
|
0.010 |
None |
1.000 |
1 |
|
1999 |
1999 |
Calcification of coronary artery
|
phenotype |
Nutritional and Metabolic Diseases; Cardiovascular Diseases
|
Pathologic Function
|
51
|
205
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Carcinoma of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
4081
|
1204
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Cardiac troponin I measurement
|
phenotype |
|
Laboratory Procedure
|
11
|
14
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Cardiovascular Diseases
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
1756
|
711
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Carotid Artery Thrombosis
|
disease |
Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
30
|
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |
Central nervous system lesion
|
disease |
|
Disease or Syndrome
|
34
|
1
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Cerebrovascular accident
|
group |
Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
1658
|
591
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Chemical Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
71
|
2
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Chronic idiopathic urticaria
|
disease |
Skin and Connective Tissue Diseases; Immune System Diseases
|
Disease or Syndrome
|
89
|
9
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Chronic kidney disease stage 5
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
666
|
194
|
0.020 |
None |
1.000 |
2 |
2
|
1998 |
2000 |
Chronic Kidney Diseases
|
group |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
1074
|
306
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Chronic Lymphocytic Leukemia
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1447
|
291
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Chronic Obstructive Airway Disease
|
disease |
Respiratory Tract Diseases
|
Disease or Syndrome
|
1428
|
852
|
0.010 |
None |
1.000 |
1 |
1
|
2014 |
2014 |